Are you an ambitious procurement expert with recent publications? Check out the TED Ambassador award, our competition that aims to identify and reward research in the field of public procurement. Apply here by 28 April 2023.

Services - 24518-2018
18/01/2018    S12

Turkey-Bilkent Çankaya: Research and experimental development services

2018/S 012-024518

Contract notice

Services

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: Türkiye Cumhuriyeti Sağlık Bakanlığı
National registration number: TR8150291462
Postal address: Üniversiteler Mah. Dumlupınar Bul. 6001. Cad. No.: 9
Town: Bilkent Çankaya Ankara
NUTS code: TR7 ORTA ANADOLU
Postal code: 06800
Country: Turkey
Contact person: Ozan Beyhan
E-mail: ozan.beyhan@saglik.gov.tr
Telephone: +90 3124718350
Fax: +90 3124718297
Internet address(es):
Main address: www.proempower-pcp.eu
I.1)Name and addresses
Official name: Servicio Murciano de Salud
National registration number: ESQ8050008E
Postal address: C Central 7
Town: Murcia
NUTS code: ES620 Murcia
Postal code: 30100
Country: Spain
Contact person: Gorka Sanchez
E-mail: gorka.sanchez@carm.es
Internet address(es):
Main address: www.proempower-pcp.eu
I.1)Name and addresses
Official name: Società Regionale per la Sanità (So.Re.Sa) S.p.A.
Postal address: Complesso Esedra, Centro Direzionale is. F9
Town: Napoli
NUTS code: ITF33 Napoli
Postal code: 80143
Country: Italy
Contact person: Direzione Generale
E-mail: innovazione@soresa.it
Telephone: +39 0812128174
Internet address(es):
Main address: www.proempower-pcp.eu
I.1)Name and addresses
Official name: Servicos Partilhados do Ministerio da Saude Epe
National registration number: PT509540716
Postal address: Avenida da República n.º 61
Town: Lisboa
NUTS code: PT170 Not specified
Postal code: 1050-189
Country: Portugal
Contact person: Diogo Bento Martins
E-mail: diogo.martins@spms.min-saude.pt
Internet address(es):
Main address: www.proempower-pcp.eu
I.2)Information about joint procurement
The contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law:

Turkish.

I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: http://proempower-pcp.eu/call-for-tender/tender-documents.html
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: http://proempower-pcp.eu
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Pre–commercial procurement (PCP) to buy R&D (research & development) services to improve the treatment and self-management of diabetes type 2 patients using a Personalised Diabetes Management Solution

II.1.2)Main CPV code
73100000 Research and experimental development services
II.1.3)Type of contract
Services
II.1.4)Short description:

This contract notice invites interested operators to submit tenders to a procurement.

The procurement aims to trigger new solutions to be developed and tested to address the challenge of providing more effective management of diabetes type2 patients tackling the rising incidence rate of diabetes through a personalised diabetes management solution.

The main areas to be addressed are: person-centred care, personalised care: multi-disciplinary care, early detection, personalised decision support, self-management support, self-help and peer support, a learning healthcare system, interoperability and integration.

More information can be found on the ProEmpower website: http://proempower-pcp.eu/

This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called ‘buyers group’).

II.1.5)Estimated total value
Value excluding VAT: 3 000 000.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.2)Additional CPV code(s)
32441100 Telemetry surveillance system
32441300 Telematics system
48814400 Clinical information system
48814000 Medical information systems
48814200 Patient-administration system
48180000 Medical software package
33000000 Medical equipments, pharmaceuticals and personal care products
33100000 Medical equipments
33190000 Miscellaneous medical devices and products
33196000 Medical aids
33195000 Patient-monitoring system
72212190 Educational software development services
72212930 Training and entertainment software development services
72212931 Training software development services
80420000 E-learning services
80320000 Medical education services
72212180 Medical software development services
80561000 Health training services
72212211 Platform interconnectivity software development services
II.2.3)Place of performance
NUTS code: TR100 Istanbul
NUTS code: PT17 Lisboa
NUTS code: ES62 Región de Murcia
NUTS code: ITF3 Campania
Main site or place of performance:

Testing is expected to take place in Amadora, PT; Murcia, ES, Naples, IT and Istanbul, TR. At least 50 % of the contracted R&D services must be in EU Member States or Horizon 2020 associated countries.

II.2.4)Description of the procurement:

The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected operator will be awarded a framework agreement that covers three R&D phases. The three phases are: solution design, prototyping, original development, and validation and testing of a limited set of first products or services. After each phase, intermediate evaluations will be carried out to select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.

The procurement is expected to start in May 2018 and end in March 2020.

The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions i.e. beyond the procurers.

This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.

Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.

The open procedure was chosen for formal reasons only. This is because it is not possible to publish a contract notice without selecting one of the listed procedures.

Tenders must be submitted in English. Deliverables must be submitted in English. The PCP language is English and the framework agreement and the specific phase contract must be signed in the English version. Communication (relating to either the tender procedure or the implementation of the contract) must be carried out in English. For field testing in phase 3 the ability to speak the local languages (Spanish, Italian, Turkish and Portuguese) will be an advantage.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
Value excluding VAT: 3 000 000.00 EUR
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Start: 01/05/2018
End: 31/03/2020
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: yes
Identification of the project: This project receives funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 727409.
II.2.14)Additional information

This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them.

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

For further information please read the procurement documents.

III.1.2)Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:

For further information please read the procurement documents.

III.2.3)Information about staff responsible for the performance of the contract
Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
Notice number in the OJ S: 2017/S 059-111138
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 21/03/2018
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
IV.2.7)Conditions for opening of tenders
Date: 22/03/2018
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
Electronic payment will be used
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: Ankara courts
Town: Ankara
Country: Turkey
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

The procurement is exempted from the EU public procurement directives (including the EU procurement remedies directives Council Directive 89/665/EEC and Council Directive 92/13/EEC — see above) and the national laws that implement them. Publication of this notice in the Official Journal is not to be understood as a waiver of this exemption by the contracting authority.

VI.4.4)Service from which information about the review procedure may be obtained
Official name: Türkiye Cumhuriyeti Sağlık Bakanlığı
Postal address: Üniversiteler Mah. Dumlupınar Bul. 6001. Cad. No.: 9
Town: Bilkent Çankaya Ankara
Postal code: 06800
Country: Turkey
E-mail: ozan.beyhan@saglik.gov.tr
Telephone: +90 3124718350
Fax: +90 3124718297
Internet address: www.proempower-pcp.eu
VI.5)Date of dispatch of this notice:
16/01/2018